Skip to main content

Supportive Care in Cancer

Ausgabe 8/2013

Inhalt (34 Artikel)

Letter to the editor

Accidental falls in home care hematological patients

A. Tendas, L. Cupelli, M. M. Trawinska, L. Lentini, M. Giovannini, L. Scaramucci, M. Palombi, G. A. Brunetti, C. Cartoni, P. de Fabritiis, P. Niscola, F. Mandelli

Original Article

Factors that affect sleep quality: perceptions made by patients in the intensive care unit after thoracic surgery

Lei Zhang, Yong Sheng Sha, Qing Qing Kong, Jennifer Ai-lian Woo, Adam R Miller, Hong Wei Li, Li Xin Zhou, Yi Zhou, Chang Li Wang

Original Article

Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients

Masatoshi Inagaki, Tatsuo Akechi, Toru Okuyama, Yuriko Sugawara, Hiroya Kinoshita, Yasuo Shima, Kimio Terao, Shuichi Mitsunaga, Atsushi Ochiai, Yosuke Uchitomi

Original Article

Distress screening remains important during follow-up after primary breast cancer treatment

Floortje K. Ploos van Amstel, Sanne W. van den Berg, Hanneke W. M. van Laarhoven, Marieke F. M. Gielissen, Judith B. Prins, Petronella B. Ottevanger

Original Article

Exploring the use of the survivorship consult in providing survivorship care

David Wiljer, Sara Urowitz, Jennifer Jones, Ashley Kornblum, Scott Secord, Pamela Catton

Original Article

Correlates of elevated distress thermometer scores in breast cancer patients

Jayant Agarwal, Karen Powers, Lisa Pappas, Luke Buchmann, Layla Anderson, Lisa Gauchay, Anne Rich

Original Article

Impact of oral mucositis on short-term clinical outcomes in paediatric and adolescent patients undergoing chemotherapy

Karis Kin Fong Cheng, Vincent Lee, Chak Ho Li, Hui Leung Yuen, Wan Yim Ip, Hong Gu He, Joel B. Epstein

Original Article

Association of social network and social support with health-related quality of life and fatigue in long-term survivors of Hodgkin lymphoma

A. Soares, I. Biasoli, A. Scheliga, R. L. Baptista, E. P. Brabo, J. C. Morais, G. L. Werneck, N. Spector

Original Article

Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients

Shinichiro Morishita, Katsuji Kaida, Shinya Yamauchi, Koichiro Sota, Shinichi Ishii, Kazuhiro Ikegame, Norihiko Kodama, Hiroyasu Ogawa, Kazuhisa Domen

Original Article

Exploring clinical determinants and anxiety symptom domains among Asian breast cancer patients

Yin Ting Cheung, Helen Hoi-Lun Lee, Alexandre Chan

Original Article

Understanding how cancer patients actualise, relinquish, and reject advance care planning: implications for practice

Natasha Michael, Clare O’Callaghan, Josephine Clayton, Annabel Pollard, Nikola Stepanov, Odette Spruyt, Michael Michael, David Ball

Original Article

Transient swelling versus lymphoedema in the first year following surgery for breast cancer

Sharon L. Kilbreath, Mi-Joung Lee, Kathryn M. Refshauge, Jane M. Beith, Leigh C. Ward, J. M. Simpson, D. Black

Original Article

The poor use of methadone in Italian hospices

Sebastiano Mercadante, Alessandro Valle, Cristina Agnelotti, Amanda Caruselli

Original Article

Dosimetric and clinical impact of 3D vs. 2D planning in palliative radiotherapy for bone metastases

Kathy Pope, David Fitzpatrick, Andrew Potter, Michael Holwell, Lisa Wang, Michelle Lau, Wilfred Levin, Michael McLean, Laura Zurawel Balaura, Andrea Bezjak, Rebecca K. S. Wong

Original Article

Suboptimal health literacy in patients with lung cancer or head and neck cancer

Kelvin Koay, Penelope Schofield, Karla Gough, Rachelle Buchbinder, Danny Rischin, David Ball, June Corry, Richard H. Osborne, Michael Jefford

Original Article

Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy

Caroline C. Henson, Susan E. Davidson, Yeng Ang, Chris Babbs, John Crampton, Mark Kelly, Simon Lal, Jimmy K. Limdi, Greg Whatley, Ric Swindell, Wendy Makin, John McLaughlin

Original Article

The impact of clinical and sociodemographic features on quality of life in patients with early stage cancers using the Functional Assessment of Cancer Therapy-General assessment tool

Marko Popovic, Nicholas Lao, Liang Zeng, Liying Zhang, David Cella, Jennifer L. Beaumont, Ronald Chow, Nicholas Chiu, Leonard Chiu, Henry Lam, Michael Poon, Edward Chow

Original Article

The role of physical activity and physical fitness in postcancer fatigue: a randomized controlled trial

H. Prinsen, G. Bleijenberg, L. Heijmen, M. J. Zwarts, J. W. H. Leer, A. Heerschap, M. T. E. Hopman, H. W. M. van Laarhoven

Original Article

Virtual navigation in colorectal cancer and melanoma: an exploration of patients’ views

Carmen G. Loiselle, Okimi Peters, Kristen R. Haase, Laurence Girouard, Annett Körner, David Wiljer, Margaret Fitch

Original Article

Predictors of acute adverse events from rapid rituximab infusion

Dora S. P. Lang, Dorothy M. K. Keefe, Tim Schultz, Alan Pearson

Original Article

Multidisciplinary care in patients with prostate cancer: room for improvement

Räto T. Strebel, Tullio Sulser, Hans-Peter Schmid, Silke Gillessen, Martin Fehr, Urs Huber, Miklos Pless, Rudolf Morant, Ralph Winterhalder, Richard Cathomas

Original Article

The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting

Sebastiano Mercadante, Giampiero Porzio, Federica Aielli, Lucilla Averna, Corrado Ficorella, Alessandra Casuccio

Review Article

Prognostic impact of the combination of erythropoiesis-stimulating agents to cancer treatment: literature review

L. Boulaamane, A. Goncalves, S. Boutayeb, P. Viens, H. M’rabti, F. Bertucci, H. Errihani

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.